225Actinium-PSMA-I&T
- Generic Name
- 225Actinium-PSMA-I&T
FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Fusion Pharmaceuticals Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT06909825
- Locations
- 🇦🇺
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
🇦🇺Macquarie University Hospital, Macquarie Park, New South Wales, Australia
🇦🇺Icon Cancer Centre North Lakes, North Lakes, Queensland, Australia
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Fusion Pharmaceuticals Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06402331
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸Hoag Health Center Irvine, Irvine, California, United States
🇺🇸VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Targeted Alpha Therapy with 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).
Phase 2
Active, not recruiting
- Conditions
- Metastatic Castration Resistant Prostate Cancer
- Interventions
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Fusion Pharmaceuticals Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT05219500
- Locations
- 🇺🇸
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, United States
🇺🇸XCancer Omaha/Urology Cancer Center, Omaha, Nebraska, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath